No photo of Emma I. Andersson
  • Finland

20122018
If you made any changes in Pure these will be visible here soon.

International and National Collaboration Publications and projects within past five years.

Publications 2012 2018

Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL

Schrader, A., Crispatzu, G., Oberbeck, S., Mayer, P., Pützer, S., von Jan, J., Vasyutina, E., Warner, K., Weit, N., Pflug, N., Braun, T., Andersson, E. I., Yadav, B., Riabinska, A., Maurer, B., Ferreira, M. S. V., Beier, F., Altmueller, J., Lanasa, M., Herling, C. D. & 16 othersHaferlach, T., Stilgenbauer, S., Hopfinger, G., Peifer, M., Brümmendorf, T. H., Nürnberg, P., Elenitoba-Johnson, K. S. J., Zha, S., Hallek, M., Moriggl, R., Reinhardt, H. C., Stern, M. -H., Mustjoki, S., Newrzela, S., Frommolt, P. & Herling, M., 15 Feb 2018, In : Nature Communications. 9, 22 p., 697.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

ADA2 deficiency: Clonal lymphoproliferation in a subset of patients

Trotta, L., Martelius, T., Siitonen, T., Hautala, T., Hämäläinen, S., Juntti, H., Taskinen, M., Ilander, M., Andersson, E. I., Zavialov, A., Kaustio, M., Keski-Filppula, R., Hershfield, M., Mustjoki, S., Tapiainen, T., Seppänen, M. & Saarela, J., Apr 2018, In : Journal of Allergy and Clinical Immunology. 141, 4, p. 1534-+ 12 p.

Research output: Contribution to journalLetterScientificpeer-review

Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target

Dufva, O., Kankainen, M., Kelkka, T., Sekiguchi, N., Awad, S. A., Eldfors, S., Yadav, B., Kuusanmäki, H., Malani, D., Andersson, E. I., Pietarinen, P., Saikko, L., Kovanen, P. E., Ojala, T., Lee, D. A., Loughran, T. P., Nakazawa, H., Suzumiya, J., Suzuki, R., Ko, Y. H. & 7 othersKim, W. S., Chuang, S-S., Aittokallio, T., Chan, W. C., Ohshima, K., Ishida, F. & Mustjoki, S., 19 Apr 2018, In : Nature Communications. 9, 12 p., 1567.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling

Andersson, E. I., Pützer, S., Yadav, B., Dufva, O., Khan, S., He, L., Sellner, L., Schrader, A., Crispatzu, G., Oleś, M., Zhang, H., Adnan-Awad, S., Lagström, S., Bellanger, D., Mpindi, J. P., Eldfors, S., Pemovska, T., Pietarinen, P., Lauhio, A., Tomska, K. & 19 othersCuesta-Mateos, C., Faber, E., Koschmieder, S., Brümmendorf, T. H., Kytölä, S., Savolainen, E-R., Siitonen, T., Ellonen, P., Kallioniemi, O., Wennerberg, K., Ding, W., Stern, M-H., Huber, W., Anders, S., Tang, J., Aittokallio, T., Zenz, T., Herling, M. & Mustjoki, S., Mar 2018, In : Leukemia. 32, 3, p. 774-787 14 p.

Research output: Contribution to journalArticleScientificpeer-review

Divergent roles for antigenic drive in the aetiology of primary versus dasatinib-associated CD8(+) TCR-Vβ(+) expansions

Lissina, A., McLaren, J. E., Ilander, M., Andersson, E. I., Lewis, C. S., Clement, M., Herman, A., Ladell, K., Llewellyn-Lacey, S., Miners, K. L., Gostick, E., Melenhorst, J. J., Barrett, A. J., Price, D. A., Mustjoki, S. & Wooldridge, L., 7 Feb 2018, In : Scientific Reports. 8, 12 p., 2534.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Prizes

Helsinki Challenge

Jing Tang (Recipient), Samu Kurki (Recipient), Tero Aittokallio (Recipient), Emma I. Andersson (Recipient), Evgeny Kulesskiy (Recipient), Ashwini Kumar (Recipient), Dimitrios Tsallos (Recipient), Muntasir Majumder (Recipient), Olli Dufva (Recipient) & Mikko Keränen (Recipient), 22 Nov 2017

Prize: Prizes and awards